Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations - 21/08/11
Doi : 10.1016/S1470-2045(05)70097-8
Eva Wardelmann, DrMD a, ⁎ 
, Nadja Thomas a, Sabine Merkelbach-Bruse, PhD a, Katharina Pauls, MD a, Nicola Speidel, MD b, Reinhard Büttner, MD a, Heiner Bihl, MD e, Claudia C Leutner, MD c, Thomas Heinicke, MD d, Peter Hohenberger, MD f
, Nadja Thomas a, Sabine Merkelbach-Bruse, PhD a, Katharina Pauls, MD a, Nicola Speidel, MD b, Reinhard Büttner, MD a, Heiner Bihl, MD e, Claudia C Leutner, MD c, Thomas Heinicke, MD d, Peter Hohenberger, MD f a Department of Pathology, University of Bonn Medical Center, Germany
b Department of Surgery, University of Bonn Medical Center, Germany
c Department of Radiology, University of Bonn Medical Center, Germany
d Department of Internal Medicine, University of Bonn Medical Center, Germany
e Department of Nuclear Medicine, St-Katharinen-Hospital, Stuttgart, Germany
f Department of Surgery and Division of Surgical Oncology and Thoracal Surgery, University of Heidelberg, Germany
* Correspondence to: Dr Eva Wardelmann, Department of Pathology, University of Bonn Medical School, PO Box 2120, D-53011 Bonn, Germany
© 2005
Elsevier Ltd. Tous droits réservés.
Vol 6 - N° 4
P. 249-251 - avril 2005 Retour au numéro
Article précédent
- Does the vagus nerve inform the brain about preclinical tumours and modulate them?
- Yori Gidron, Hugh Perry, Martin Glennie
- Tumour response to paclitaxel in an adult with relapsed nephroblastoma
- Antoine Italiano, Nicolas Sirvent, Jean-François Michiels, Frédéric Peyrade, Josiane Otto, Antoine Thyss
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?